Recombinant Influenza Virus Carrying the Respiratory Syncytial Virus (RSV) F85-93 CTL Epitope Reduces RSV Replication in Mice

被引:26
作者
De Baets, Sarah [1 ,2 ]
Schepens, Bert [1 ,2 ]
Sedeyn, Koen [1 ,2 ]
Schotsaert, Michael [1 ,2 ]
Roose, Kenny [1 ,2 ]
Bogaert, Pieter [1 ,2 ]
Fiers, Walter [1 ,2 ]
Saelens, Xavier [1 ,2 ]
机构
[1] VIB, Dept Mol Biomed Res, Ghent, Belgium
[2] Univ Ghent, Dept Biomed Mol Biol, B-9000 Ghent, Belgium
关键词
CD8; T-CELLS; PULMONARY EOSINOPHILIA; PRIMARY INFECTION; PROTECTION; RESPONSES; LUNG; PATHOGENESIS; REINFECTION; IMMUNITY; INFANTS;
D O I
10.1128/JVI.03019-12
中图分类号
Q93 [微生物学];
学科分类号
071005 ; 100705 ;
摘要
Respiratory syncytial virus (RSV) is the leading cause of lower respiratory tract infections in infants worldwide. Despite decades of research, there is still no registered vaccine available for this major pathogen. We investigated the protective efficacy of a recombinant influenza virus, PR8/NA-F85-93, that carries the RSV CD8(+) T cell epitope F85-93 in its neuraminidase stalk. F85-93-specific cytotoxic T lymphocytes (CTLs) were induced in mice after a single intranasal immunization with PR8/NA-F85-93 virus, and these CTLs provided a significant reduction in the lung viral load upon a subsequent challenge with RSV. To avoid influenza-induced morbidity, we treated mice with matrix protein 2 (M2e)-specific monoclonal antibodies before PR8/NA-F85-93 virus infection. Treatment with anti-M2e antibodies reduced the infiltration of immune cells in the lungs upon PR8/NA-F85-93 infection, whereas the formation of inducible bronchus-associated lymphoid tissue was not affected. Moreover, this treatment prevented body weight loss yet still permitted the induction of RSV F-specific T cell responses and significantly reduced RSV replication upon challenge. These results demonstrate that it is possible to take advantage of the infection-permissive protection of M2e-specific antibodies against influenza A virus to induce heterologous CD8(+) T cell-mediated immunity by an influenza A virus vector expressing the RSV F85-93 epitope.
引用
收藏
页码:3314 / 3323
页数:10
相关论文
共 41 条
[1]  
Bacharier LB, 2012, J ALLERGY CLIN IMMUN, V130
[2]   Inflammatory signatures for eosinophilic vs. neutrophilic allergic pulmonary inflammation reveal critical regulatory checkpoints [J].
Bogaert, Pieter ;
Naessens, Thomas ;
De Koker, Stefaan ;
Hennuy, Benoit ;
Hacha, Jonathan ;
Smet, Muriel ;
Cataldo, Didier ;
Di Valentin, Emmanuel ;
Piette, Jacques ;
Tournoy, Kurt G. ;
Grooten, Johan .
AMERICAN JOURNAL OF PHYSIOLOGY-LUNG CELLULAR AND MOLECULAR PHYSIOLOGY, 2011, 300 (05) :L679-L690
[3]   Protective T cell immunity against respiratory syncytial virus is efficiently induced by recombinant BCG [J].
Bueno, Susan M. ;
Gonzalez, Pablo A. ;
Cautivo, Kelly M. ;
Mora, Jorge E. ;
Leiva, Eduardo D. ;
Tobar, Hugo E. ;
Fennelly, Glenn J. ;
Eugenin, Eliseo A. ;
Jacobs, William R., Jr. ;
Riedel, Claudia A. ;
Kalergis, Alexis M. .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2008, 105 (52) :20822-20827
[4]   CYTO-TOXIC T-CELLS CLEAR VIRUS BUT AUGMENT LUNG PATHOLOGY IN MICE INFECTED WITH RESPIRATORY SYNCYTIAL VIRUS [J].
CANNON, MJ ;
OPENSHAW, PJM ;
ASKONAS, BA .
JOURNAL OF EXPERIMENTAL MEDICINE, 1988, 168 (03) :1163-1168
[5]   PROTECTION AGAINST LETHAL LYMPHOCYTIC CHORIOMENINGITIS VIRUS (LCMV) INFECTION BY IMMUNIZATION OF MICE WITH AN INFLUENZA-VIRUS CONTAINING AN LCMV EPITOPE RECOGNIZED BY CYTOTOXIC T-LYMPHOCYTES [J].
CASTRUCCI, MR ;
HOU, S ;
DOHERTY, PC ;
KAWAOKA, Y .
JOURNAL OF VIROLOGY, 1994, 68 (06) :3486-3490
[6]  
Centers for Disease Control and Prevention, 2010, RESP SYNC VIR INF RS
[7]  
Centers for Disease Control and Prevention, 2012, INFL VACC LIV INTR W
[8]   Influenza virus: Immunity and vaccination strategies. Comparison of the immune response to inactivated and live, attenuated influenza vaccines [J].
Cox, RJ ;
Brokstad, KA ;
Ogra, P .
SCANDINAVIAN JOURNAL OF IMMUNOLOGY, 2004, 59 (01) :1-15
[9]   Universal Vaccine Based on Ectodomain of Matrix Protein 2 of Influenza A: Fc Receptors and Alveolar Macrophages Mediate Protection [J].
El Bakkouri, Karim ;
Descamps, Francis ;
De Filette, Marina ;
Smet, Anouk ;
Festjens, Els ;
Birkett, Ashley ;
Van Rooijen, Nico ;
Verbeek, Sjef ;
Fiers, Walter ;
Saelens, Xavier .
JOURNAL OF IMMUNOLOGY, 2011, 186 (02) :1022-1031
[10]  
European Medicines Agency, 2012, ASS REP FLUENZ